Thanks to new treatments, more people survive histiocytic neoplasms, but their survival comes with challenges, according to findings published in Blood.
Systemic mastocytosis (SM) involves multiple underlying symptoms at presentation and several disease subtypes that are difficult to diagnose quickly, according to results published in the Journal of Oncology Pharmacy Practice....
Complement inhibitors have positive, sustained benefits for patients with paroxysmal nocturnal hemoglobinuria (PNH), according to findings published in Therapeutic Advances in Hematology. Hae Sun Suh, PhD, and colleagues...
Physicians must remember they took an oath to “do no harm” and must act in accordance with it, even if their choices do not meet a patient’s preferences.